SANUWAVE Health, Inc.  

(Public, OTCBB:SNWV)   Watch this stock  
Find more results for SNWV)
+0.015 (2.65%)
Apr 23 - Close
OTCBB data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.56 - 0.58
52 week 0.45 - 1.42
Open 0.56
Vol / Avg. 30,434.00/81,790.00
Mkt cap 27.14M
P/E     -
Div/yield     -
EPS -0.51
Shares 46.80M
Beta 110.99
Inst. own 10%
Apr 23, 2014
Sanuwave Health Inc at Redchip Virtual Conference

Key stats and ratios

Q3 (Sep '13) 2012
Net profit margin -2989.35% -832.21%
Operating margin -2646.81% -788.11%
EBITD margin - -745.58%
Return on average assets -1053.47% -159.70%
Return on average equity - -
Employees 11 -
CDP Score - -


Suite 150, 11475 Great Oaks Way
United States - Map
+1-678-5816843 (Phone)
+1-770-4198634 (Fax)

Website links


SANUWAVE Health, Inc. is a regenerative medicine company focused on the development and commercialization of noninvasive, biological response activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's portfolio of products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration.The Company is focused on developing its Pulsed Acoustic Cellular Expression (PACE) technology to activate healing in wound conditions, including diabetic foot ulcers, venous ulcers, pressure sores, burns and other skin eruption conditions; orthopedic/spine applications.

Officers and directors

Kevin A. Richardson II Chairman of the Board, Co-Chief Executive Officer
Age: 45
Barry J. Jenkins Chief Financial Officer, Chief Operating Officer
Age: 50
Joseph Chiarelli Director
Age: 66
John F. Nemelka Director
Age: 48
Alan L. Rubino Director
Age: 58